Literature DB >> 33477404

A Phase IIb Randomized Controlled Trial Investigating the Effects of Tocotrienol-Rich Vitamin E on Diabetic Kidney Disease.

Yan Yi Koay1, Gerald Chen Jie Tan1, Sonia Chew Wen Phang1, J-Ian Ho1, Pei Fen Chuar1, Loon Shin Ho1, Badariah Ahmad1, Khalid Abdul Kadir1.   

Abstract

Diabetic kidney disease (DKD) is a debilitating complication of diabetes, which develops in 40% of the diabetic population and is responsible for up to 50% of end-stage renal disease (ESRD). Tocotrienols have shown to be a potent antioxidant, anti-inflammatory, and antifibrotic agent in animal and clinical studies. This study evaluated the effects of 400 mg tocotrienol-rich vitamin E supplementation daily on 59 DKD patients over a 12-month period. Patients with stage 3 chronic kidney disease (CKD) or positive urine microalbuminuria (urine to albumin creatinine ratio; UACR > 20-200 mg/mmol) were recruited into a randomized, double-blind, placebo-controlled trial. Patients were randomized into either intervention group (n = 31) which received tocotrienol-rich vitamin E (Tocovid SupraBioTM; Hovid Berhad, Ipoh, Malaysia) 400 mg daily or a placebo group which received placebo capsules (n = 28) for 12 months. HbA1c, renal parameters (i.e., serum creatinine, eGFR, and UACR), and serum biomarkers were collected at intervals of two months. Tocovid supplementation significantly reduced serum creatinine levels (MD: -4.28 ± 14.92 vs. 9.18 ± 24.96), p = 0.029, and significantly improved eGFR (MD: 1.90 ± 5.76 vs. -3.29 ± 9.24), p = 0.011 after eight months. Subgroup analysis of 37 patients with stage 3 CKD demonstrated persistent renoprotective effects over 12 months; Tocovid improved eGFR (MD: 4.83 ± 6.78 vs. -1.45 ± 9.18), p = 0.022 and serum creatinine (MD: -7.85(20.75) vs. 0.84(26.03), p = 0.042) but not UACR. After six months post washout, there was no improvement in serum creatinine and eGFR. There were no significant changes in the serum biomarkers, TGF-β1 and VEGF-A. Our findings verified the results from the pilot phase study where tocotrienol-rich vitamin E supplementation at two and three months improved kidney function as assessed by serum creatinine and eGFR but not UACR.

Entities:  

Keywords:  anti-inflammatory; antifibrotic; antioxidant; diabetic kidney disease; tocotrienols; transforming growth factor-beta 1 (TGF-β1); vitamin E

Mesh:

Substances:

Year:  2021        PMID: 33477404      PMCID: PMC7830596          DOI: 10.3390/nu13010258

Source DB:  PubMed          Journal:  Nutrients        ISSN: 2072-6643            Impact factor:   5.717


  30 in total

1.  Comparative antioxidant activity of tocotrienols and the novel chromanyl-polyisoprenyl molecule FeAox-6 in isolated membranes and intact cells.

Authors:  Paola Palozza; Sara Verdecchia; Luca Avanzi; Silvia Vertuani; Simona Serini; Anna Iannone; Stefano Manfredini
Journal:  Mol Cell Biochem       Date:  2006-04-28       Impact factor: 3.396

2.  A study of the natural history of diabetic kidney disease (DKD).

Authors:  Nagi Altemtam; Jean Russell; Meguid El Nahas
Journal:  Nephrol Dial Transplant       Date:  2011-11-05       Impact factor: 5.992

3.  Diabetic Kidney Disease: Challenges, Progress, and Possibilities.

Authors:  Radica Z Alicic; Michele T Rooney; Katherine R Tuttle
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-18       Impact factor: 8.237

Review 4.  What can target kidney fibrosis?

Authors:  Irina A Leaf; Jeremy S Duffield
Journal:  Nephrol Dial Transplant       Date:  2017-01-01       Impact factor: 5.992

5.  Protective effects of tocotrienols against lipid-induced nephropathy in experimental type-2 diabetic rats by modulation in TGF-β expression.

Authors:  Shabeena Siddiqui; Haseeb Ahsan; Mohammad Rashid Khan; Waseem A Siddiqui
Journal:  Toxicol Appl Pharmacol       Date:  2013-09-14       Impact factor: 4.219

Review 6.  Vitamin E therapy beyond cancer: Tocopherol versus tocotrienol.

Authors:  Hong Yong Peh; W S Daniel Tan; Wupeng Liao; W S Fred Wong
Journal:  Pharmacol Ther       Date:  2015-12-17       Impact factor: 12.310

Review 7.  Serum TGF-β1 as a Biomarker for Type 2 Diabetic Nephropathy: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Xin Mou; Di-Yi Zhou; Dan-Yang Zhou; Jing-Ru Ma; Ying-Hui Liu; Hui-Ping Chen; Yong-Bin Hu; Cheng-Min Shou; Jia-Wei Chen; Wen-Hong Liu; Guo-Ling Ma
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

8.  Validation of a HPLC/FLD Method for Quantification of Tocotrienols in Human Plasma.

Authors:  Hui-Ling Che; Doryn Meam-Yee Tan; Puvaneswari Meganathan; Yee-Lin Gan; Ghazali Abdul Razak; Ju-Yen Fu
Journal:  Int J Anal Chem       Date:  2015-10-28       Impact factor: 1.885

9.  The global burden of kidney disease and the sustainable development goals.

Authors:  Valerie A Luyckx; Marcello Tonelli; John W Stanifer
Journal:  Bull World Health Organ       Date:  2018-04-20       Impact factor: 9.408

10.  Tocotrienol-rich vitamin E improves diabetic nephropathy and persists 6-9 months after washout: a phase IIa randomized controlled trial.

Authors:  Gerald Chen Jie Tan; Suzanne May Quinn Tan; Sonia Chew Wen Phang; Yeek Tat Ng; En Yng Ng; Badariah Ahmad; Uma Devi M Palamisamy; Khalid Abdul Kadir
Journal:  Ther Adv Endocrinol Metab       Date:  2019-12-25       Impact factor: 3.565

View more
  5 in total

Review 1.  Revisiting the therapeutic potential of tocotrienol.

Authors:  Ranmali Ranasinghe; Michael Mathai; Anthony Zulli
Journal:  Biofactors       Date:  2022-06-20       Impact factor: 6.438

Review 2.  Vitamin E (Alpha-Tocopherol) Metabolism and Nutrition in Chronic Kidney Disease.

Authors:  Francesco Galli; Mario Bonomini; Desirée Bartolini; Linda Zatini; Gianpaolo Reboldi; Giada Marcantonini; Giorgio Gentile; Vittorio Sirolli; Natalia Di Pietro
Journal:  Antioxidants (Basel)       Date:  2022-05-18

Review 3.  Vitamin E beyond Its Antioxidant Label.

Authors:  Anca Ungurianu; Anca Zanfirescu; Georgiana Nițulescu; Denisa Margină
Journal:  Antioxidants (Basel)       Date:  2021-04-21

Review 4.  Cellular crosstalk of glomerular endothelial cells and podocytes in diabetic kidney disease.

Authors:  Shan Jiang; Manyu Luo; Xue Bai; Ping Nie; Yuexin Zhu; Hangxi Cai; Bing Li; Ping Luo
Journal:  J Cell Commun Signal       Date:  2022-01-18       Impact factor: 5.908

5.  Identifying Potential Diagnostic Genes for Diabetic Nephropathy Based on Hypoxia and Immune Status.

Authors:  Changyan Li; Feng Su; Le Zhang; Fang Liu; Wenxing Fan; Zhen Li; JingYuan Ma
Journal:  J Inflamm Res       Date:  2021-12-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.